BMY
🟢 Bristol-Myers Squibb is trading 7.6% up today after strong Q2 earnings and a guidance hike
Bristol-Myers Squibb is trading at $70.24 (7.6% up) today following a strong Q2 2026 earnings report and a substantial full-year guidance raise.
• Management...
